SLS SELLAS LIFE SCIENCES GROUP INC Other Situations 8-K Filing 2023 - Update on Clinical Trial SELLAS Life Sciences Group, Inc. provided an update on its Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia.Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC